Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR1H3 | Q13133 | 15/20 | 0.47 |
| ▸ | NR1H2 | P55055 | 13/20 | 0.47 |
| ▸ | AR | P10275 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | RORC | P51449 | 2/20 | 0.37 |
| ▸ | RORA | P35398 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23040270 | 0.86 | NR1H3 (0.53) | NR1H3NR1H2MEN1ALOX15TSHR | |
| SCHEMBL7734267 | 0.80 | TSHR (0.48) | TSHRMAPK1 | |
| SCHEMBL832913 | 0.80 | NR1H3 (0.47) | NR1H3NR1H2ARMEN1ALOX15 | |
| SCHEMBL23040284 | 0.78 | NR1H2 (0.63) | NR1H3NR1H2 | |
| SCHEMBL23040277 | 0.77 | NR1H3 (0.47) | NR1H3NR1H2MEN1ALOX15TSHR | |
| SCHEMBL12441430 | 0.74 | PTPN1 (0.48) | NR1H3NR1H2ARMEN1ALOX15 | |
| SCHEMBL29509593 | 0.74 | TSHR (0.50) | NR1H3NR1H2ARMEN1ALOX15 | |
| SCHEMBL24901407 | 0.74 | TSHR (0.50) | NR1H3NR1H2ARMEN1ALOX15 | |
| SCHEMBL23040287 | 0.74 | NR1H3 (0.46) | NR1H3NR1H2RORC | |
| SCHEMBL24901406 | 0.72 | KCNN4 (0.50) | NR1H3NR1H2ARMEN1ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11881400-B2 | Silicon-containing layer-forming composition, and method for producing pattern-equipped substrate which uses same | CENTRAL GLASS COMPANY, LIMITED (JP) | 2024-01-23 | — | — | US | disclosed |
| US-20230037301-A1 | NEGATIVE PHOTOSENSITIVE RESIN COMPOSITION, PATTERN STRUCTURE AND METHOD FOR PRODUCING PATTERNED CURED FILM | CENTRAL GLASS COMPANY, LIMITED (JP) | 2023-02-09 | — | — | US | disclosed |
| CN-113166548-A | Resin composition, photosensitive resin composition, cured film, method for producing cured film, patterned cured film, and method for producing patterned cured film | 中央硝子株式会社 | 2021-07-23 | — | — | CN | disclosed |
| US-20210082690-A1 | Silicon-Containing Layer-Forming Composition, and Method for Producing Pattern-Equipped Substrate Which Uses Same | CENTRAL GLASS COMPANY, LIMITED (JP) | 2021-03-18 | — | — | US | disclosed |
| US-20210061827-A1 | Silicon Compound Containing Hexafluoroisopropanol Group, and Method for Producing Same | CENTRAL GLASS COMPANY, LIMITED (JP) | 2021-03-04 | — | — | US | disclosed |
| CN-111819183-A | Silicon compound containing hexafluoroisopropanol group and method for producing same | 中央硝子株式会社 | 2020-10-23 | — | — | CN | disclosed |
| CN-111801621-A | Silicon-containing layer forming composition and method of manufacturing patterned substrate using the same | 中央硝子株式会社 | 2020-10-20 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210061827-A1 | Silicon Compound Containing Hexafluoroisopropanol Group, and Method for Producing Same | FOS, FUBP3, SF3A3 | NR1H3 731/4885NR1H2 1383/4885AR 3169/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.